Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars

Abstract

Unfortunately, it is not clear from Hernandez-Vasquez et al. if each publication is scored only once, using the institutional affiliation of the first or corresponding author, or if a given publication could be scored more than once if multiple institutions are listed. [...]combination of Sandoz and Novartis would lead to nine line listings on Table 4 instead of the desired ten. Since we do not have access to the underlying data, we look forward to the authors providing an updated Table 4. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.